Phlebitis with intravenous erythromycin.
D004917:Erythromycin / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007275:Injections, Intravenous; D010689:Phlebitis / Q000139:chemically induced*
C010948:erythromycin lactobionate; D004917:Erythromycin